334 related articles for article (PubMed ID: 17949550)
1. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity.
Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550
[TBL] [Abstract][Full Text] [Related]
2. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
[TBL] [Abstract][Full Text] [Related]
3. Galectin 3 and its binding protein in rheumatoid arthritis.
Ohshima S; Kuchen S; Seemayer CA; Kyburz D; Hirt A; Klinzing S; Michel BA; Gay RE; Liu FT; Gay S; Neidhart M
Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084
[TBL] [Abstract][Full Text] [Related]
4. Serum galectin-3 and galectin-3 binding protein levels in systemic lupus erythematosus and cutaneous lupus erythematosus.
Kalinska-Bienias A; Kowalczyk E; Bienias P; Gala K; Jagielski P; Kowalewski C
Postepy Dermatol Alergol; 2021 Apr; 38(2):274-280. PubMed ID: 34408596
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 binding protein links circulating microparticles with electron dense glomerular deposits in lupus nephritis.
Nielsen CT; Østergaard O; Rekvig OP; Sturfelt G; Jacobsen S; Heegaard NH
Lupus; 2015 Oct; 24(11):1150-60. PubMed ID: 25837289
[TBL] [Abstract][Full Text] [Related]
6. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
7. Hematological Indices May Be Useful in the Diagnosis of Systemic Lupus Erythematosus and in Determining Disease Activity in Behçet's Disease.
Yolbas S; Yildirim A; Gozel N; Uz B; Koca SS
Med Princ Pract; 2016; 25(6):510-516. PubMed ID: 27348861
[TBL] [Abstract][Full Text] [Related]
8. Levels of soluble Fas/APO-1 in patients with Behçet's disease.
Hamzaoui K; Hamzaoui A; Zakraoui L; Chabbou A
Mediators Inflamm; 1998; 7(2):111-4. PubMed ID: 9836498
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
10. Serum galectin 3, galectin 9 and galectin 3-binding proteins in patients with active and inactive inflammatory bowel disease.
Cibor D; Szczeklik K; Brzozowski B; Mach T; Owczarek D
J Physiol Pharmacol; 2019 Feb; 70(1):. PubMed ID: 31019124
[TBL] [Abstract][Full Text] [Related]
11. Identification of streptococcal proteins reacting with sera from Behçet's disease and rheumatic disorders.
Cho SB; Lee JH; Ahn KJ; Cho S; Park YB; Lee SK; Bang D; Lee KH
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S31-8. PubMed ID: 20868568
[TBL] [Abstract][Full Text] [Related]
12. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
Keskin D; Keskin G; Inal A; Ozışık L
Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
[TBL] [Abstract][Full Text] [Related]
13. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
14. The distinct expressions of interleukin-15 and interleukin-15 receptor α in Behçet's disease.
Choe JY; Lee H; Kim SG; Kim MJ; Park SH; Kim SK
Rheumatol Int; 2013 Aug; 33(8):2109-15. PubMed ID: 23417200
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity.
Yazmalar L; Batmaz İ; Sula B; Alpaycı M; Aydın F; Türkçü F; Yıldız M; Kaplan İ; Bozkurt M; Dağlı AZ; Burkan YK; Sarıyıldız MA
Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.
Nielsen CT; Lood C; Ostergaard O; Iversen LV; Voss A; Bengtsson A; Jacobsen S; Heegaard NH
Lupus Sci Med; 2014; 1(1):e000026. PubMed ID: 25452879
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke.
He XW; Li WL; Li C; Liu P; Shen YG; Zhu M; Jin XP
Sci Rep; 2017 Jan; 7():40994. PubMed ID: 28112232
[TBL] [Abstract][Full Text] [Related]
19. High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
de Souza AW; Perazzio SF; de França NR; Andrade LE; Bijl M; Westra J; Kallenberg CG
Rheumatology (Oxford); 2015 Dec; 54(12):2151-5. PubMed ID: 26170374
[TBL] [Abstract][Full Text] [Related]
20. Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.
Matsuoka N; Fujita Y; Temmoku J; Furuya MY; Asano T; Sato S; Matsumoto H; Kobayashi H; Watanabe H; Suzuki E; Kozuru H; Yastuhashi H; Migita K
PLoS One; 2020; 15(1):e0227069. PubMed ID: 31986153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
